Roche announced on Tuesday that it has received CE marking for eight new configurations for its Cobas Pro Integrated Solutions analyzer.
The new configurations have upped the clinical chemistry and immunochemistry analyzer’s testing capacity to 4,400 tests per hour, doubling its previous capacity. Laboratories can add two additional analytical units of Cobas C 503 for clinical chemistry or Cobas E 801 for immunoassays, “consolidating up to four analytical units on a single platform and thus serving the needs of high-throughput labs,” Roche said in a statement.
The addition of the new configurations allows labs to tailor their instruments to their individual needs by running more tests and simplifying sample processing and workflows, Roche said.
The Cobas Pro was designed for mid- to high-volume testing with automated maintenance and calibration. According to Roche, the required sample volume per test has been reduced by 43 percent on average by the Cobas Pro compared to previous generation systems.